SCHEMBL13272001

SCHEMBL13272001

Cc1ncnc2occ(-c3ccccc3)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 5/20 0.48
▸ FLT1 P17948 6/20 0.44
▸ AURKA O14965 4/20 0.44
▸ PLK4 O00444 3/20 0.44
▸ ROCK2 O75116 3/20 0.44
▸ MAP4K4 O95819 3/20 0.44
▸ LCK P06239 3/20 0.44
▸ LYN P07948 3/20 0.44
▸ RET P07949 3/20 0.44
▸ FLT4 P35916 3/20 0.44
▸ FLT3 P36888 3/20 0.44
▸ FRK P42685 3/20 0.44
▸ CSNK1D P48730 3/20 0.44
▸ BLK P51451 3/20 0.44
▸ IRAK1 P51617 3/20 0.44
▸ NEK2 P51955 3/20 0.44
▸ LIMK1 P53667 3/20 0.44
▸ CSNK1G2 P78368 3/20 0.44
▸ MAP4K2 Q12851 3/20 0.44
▸ STK3 Q13188 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1787724 0.80 SRC (0.47) KDRFLT1AURKAPLK4ROCK2
SCHEMBL2976034 0.80 KDR (0.67) KDRFLT1AURKAPLK4ROCK2
SCHEMBL22096095 0.80 KDR (0.45) KDRFLT1AURKAPLK4ROCK2
SCHEMBL14013994 0.78 KDR (0.68) KDRFLT1AURKAPLK4ROCK2
SCHEMBL4862834 0.76 CHEK1 (0.43) KDRFLT1AURKAPLK4ROCK2
SCHEMBL2966704 0.76 AURKA (0.50) KDRFLT1AURKAPLK4ROCK2
Ammonia Solution, Strong SCHEMBL1907515 0.75 L3MBTL1 (0.39) KDRAKT2ENPP3ENPP1MEN1
SCHEMBL14013991 0.73 KDR (0.61) KDRFLT1AURKAPLK4ROCK2
SCHEMBL13271835 0.72 TNK2 (0.68) AURKATNK2EGFRMEN1KMT2A
SCHEMBL13983963 0.71 KDR (0.53) KDRFLT1AURKAPLK4ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966218-B1 NOVEL, CYCLIC SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES BAYER SCHERING PHARMA AG (DE) 2010-07-14 — — EP disclosed
Send feedback